Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 28, 2011
Event: Extension of the expiration date for an ongoing rights offering.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on a corporate event regarding a rights offering and does not contain financial statement data.
Material Changes
Rights Offering Extension: On February 28, 2011, Nephros, Inc. announced that the expiration date of its ongoing rights offering has been extended to 5:00 p.m. Eastern time on Thursday, March 3, 2011.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the extension but does not include specific management commentary, future guidance, or risk factors within the body of this 8-K text.
Unusual Items: The extension of the rights offering deadline is the primary unusual item reported.
Investor Verification Checklist
- Verify the terms and current status of the rights offering by reviewing the press release attached as Exhibit 99.1.
- Confirm the new expiration deadline of March 3, 2011, at 5:00 p.m. Eastern time.
- Check subsequent filings for any further extensions or results of the rights offering.